引用本文:黄江新.稳心颗粒联合倍他乐克治疗冠心病心律失常疗效观察[J].中国临床新医学,2012,5(5):435-437.
【打印本页】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 1469次   下载 1079 本文二维码信息
码上扫一扫!
分享到: 微信 更多
稳心颗粒联合倍他乐克治疗冠心病心律失常疗效观察
黄江新
533700 广西,德保县人民医院内三科
摘要:
[摘要] 目的 探讨稳心颗粒联合倍他乐克治疗冠心病心律失常的临床效果。方法 将2008-06~2011-06收治的冠心病心律失常患者160例,随机分为观察组和对照组各80例。观察组使用稳心颗粒联合倍他乐克治疗,对照组使用心律平治疗,观察两组患者药物治疗效果并进行比较分析。结果 观察组的疗效和总有效率均优于对照组(P<0.01)。结论 稳心颗粒联合倍他乐克治疗冠心病心律失常疗效显著、副作用小、并发症少,但是临床用药应该考虑到患者的心功能和有无其他合并症等实际情况,注意用药个体化及避免滥用。
关键词:  心律失常  冠心病  稳心颗粒  倍他乐克
DOI:10.3969/j.issn.1674-3806.2012.05.16
分类号:R 541.4
基金项目:
Observation on curative effect of wenxinkeli combined with metoprolol in the treatment of coronary heart disease with arrhythmia
HUANG Jiang-xin
Third Department of Internal Medicine,the People′s Hospital of Debao County, Guangxi 533700,China
Abstract:
[Abstract] Objective To investigate the curative effect of coronary heart disease with arrhythmia treated with wensinkeli combined with metoprolol.Methods One hundrend and sixty patients with coronary heart disease complicated with arrhythmia treated in our hospital from June 2008 to June 2011 were randomly divided into observation group(n=80) and control group(n=80). The observation group were treated with wenxinkeli combined with metoprolol, while the control group were treated with propafenone. The clinical effects of the two groups were observed, compared and then analyzed.Results The curative effects and total effective rate of the observation group were higher than those of the control group (P<0.01).Conclusion Wenxinkeli combined with metoprolol has a good clinical effect for treatment of coronary heart disease with arrhythmia.The side effect and complications are low. However, in clinical use of drugs we should take the patients′ heart function,complications and the actual situation into account, emphasizing the individual and avoiding drug abuse.
Key words:  Arrhythmia  Coronary heart disease  Wenxinkeli  Metoprolol